Why CureVac Shares Are Trading Lower Today
CureVac NV (NASDAQ: CVAC) is trading lower Tuesday after the company announced it will focus its COVID-19 vaccine development towards the development of second-gen mRNA vaccine candidates in collaboration with GSK and to withdraw its first-gen vaccine from EMA approval process.
